Fennec Pharmaceuticals (FENC) Tops Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts FENC Hot Sheet
Join SI Premium – FREE
Fennec Pharmaceuticals (NASDAQ: FENC) reported Q1 EPS of $0.01, $0.05 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $15.11 million versus the consensus estimate of $14.65 million.
For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- OneMedNet files to register resale of up to 11.68M shares
- Jackson Financial secures $1.25B revolving credit facility
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
